BIOGEN INC.·4

Feb 12, 5:47 PM ET

Murphy Nicole 4

4 · BIOGEN INC. · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-10
Murphy Nicole
Head of Pharm Ops and Tech
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-102,2720 total
    Exercise: $0.00Exp: 2025-02-10Common Stock (2,272 underlying)
  • Exercise/Conversion

    Common Stock

    2025-02-10+2,27214,725.374 total
  • Tax Payment

    Common Stock

    2025-02-10$142.54/sh670$95,50214,055.374 total
Footnotes (1)
  • [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 10, 2022.

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT